AMPA Receptor

AMPA receptor antagonists and modulators act on glutamate-gated ion channels that carry fast excitatory transmission. The name comes from the selective agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Each receptor is a tetramer of glutamate receptor subunits 1 to 4 (GluA1 to GluA4), first cloned in 1989. Alternative splicing gives flip and flop forms of each subunit, which differ in desensitization. NBQX and DNQX are competitive quinoxalinedione antagonists that also block kainate receptors. GYKI-52466 dihydrochloride is a noncompetitive antagonist of the 2,3-benzodiazepine class. Positive modulators include cyclothiazide, which reduces desensitization, aniracetam and the ampakine Ampalex.

5 Items

  • Aniracetam
    Cat. No.
    A10078

    Aniracetam

    Aniracetam is an ampakine and nootropic of the racetam chemical class purported to be considerably more potent than piracetam.

    500 mg
    $35.00
    1 g
    $40.00
    All 4 sizes
  • TAT-GluA2 3Y
    Cat. No.
    A67110

    TAT-GluA2 3Y

    TAT-GluA2 3Y is an AMPAR inhibitor that interferes with the endocytosis of AMPA receptors, thereby blocking long-term depression (LTD) at glutamatergic synapses. This peptide has been shown to mitigate pentobarbital-induced spatial memory deficits, highlighting its potential in studying synaptic plasticity and memory-related research applications. TAT-GluA2 3Y serves as a valuable tool for exploring the mechanisms underlying synaptic transmission and cognitive function.

    5 mg
    $245.00
    10 mg
    $405.00
    All 2 sizes
  • D15
    Cat. No.
    A67182

    D15

    Synonyms: Dynamin II (828–842)

    D15 is an AMPA receptor (AMPAR) endocytosis inhibitor derived from a 15 amino acid segment of dynamin. It inhibits the interaction of dynamin with amphiphysin 1 and 2, leading to a significant increase in AMPAR excitatory postsynaptic potential (EPSC) amplitude in medium spiny neurons (MSNs) within Sapap3 knockout mice. This peptide has valuable applications in the investigation of neuropsychiatric disorders and related signaling pathways.

    1 mg
    $45.00
    5 mg
    $110.00
    All 5 sizes
  • AMPA-IN-1
    Cat. No.
    A67348

    AMPA-IN-1

    AMPA-IN-1 is a potent inhibitor of the AMPA receptor, which is critical for fast excitatory synaptic transmission and synaptic plasticity in the brain. By modulating AMPA receptor activity, AMPA-IN-1 demonstrates potential for research into various central nervous system disorders, including epilepsy. This compound may provide valuable insights into therapeutic strategies targeting excitatory neurotransmission.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AMPA-IN-2
    Cat. No.
    A67372

    AMPA-IN-2

    AMPA-IN-2 is a potent orally active inhibitor of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, efficiently crossing the blood-brain barrier. This compound demonstrates significant anti-epileptic effects by reducing neuronal excitability and attenuating glutamatergic transmission. AMPA-IN-2 is effective in the pentylenetetrazol model of epilepsy, making it a promising candidate for research in the field of epilepsy and related neuronal excitability disorders.

    Out of stock

    All 3 sizes

5 Items

Added to your cart

View Cart Checkout

    Loading...